Author

Felix Faas

University of CopenhagenORCID 0000-0002-2596-045XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:perturbation screen· 1

Frequent Co-Authors

Alexander S. HauseriD· 1 shared Andy ChevignéiD· 1 shared Fernando Salgado-PoloiD· 1 shared Joseph M. RogersiD· 1 shared Marin MaticiD· 1 shared Martin B GustavssoniD· 1 shared Martyna SzpakowskaiD· 1 shared Max MeyrathiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alexander S. HauserORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

De novo macrocyclic peptide discovery produces potent class A GPCR ligands with diverse pharmacology

Fernando Salgado-Polo, Marin Matic, Philip Rainsford, Felix Faas, Max Meyrath, Rajesh Regmi, METTE MARIE ROSENKILDE, Martyna Szpakowska, Andy Chevigné, Alexander S. Hauser, Joseph M. Rogers, Martin B Gustavsson

This study discovers potent, selective macrocyclic peptide ligands for CXCR4, a class A GPCR, demonstrating the feasibility of de novo peptide design for this receptor family.

bioRxiv · Oct 22, 2026 · PreprintPharmacology & Toxicology